News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioCapital
Ranbaxy Laboratories AIDS Drugs Won’t Be Funded by U.S. Program
September 26, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Sept. 25 (Bloomberg) -- AIDS drugs made by Ranbaxy Laboratories Ltd. won't be purchased under an American program to supply medicines to developing countries after the U.S. cited the company for violations in two of its plants.
Twitter
LinkedIn
Facebook
Email
Print
Asia
MORE ON THIS TOPIC
Manufacturing
AstraZeneca Building Shanghai Production Plant to Support Cell Therapy Strategy
March 19, 2026
·
2 min read
·
Nick Paul Taylor
China
Lilly Pumps $3B Into China To Boost Supply of Weight Loss Pill
March 11, 2026
·
2 min read
·
Tristan Manalac
Collaboration
Roche Broadens Global Clinical Trial Footprint With $480M+ South Korea Pledge
March 5, 2026
·
1 min read
·
Tristan Manalac
Immunology and inflammation
Sanofi Bets Up to $1.53B in Hong Kong Immuno Pact, Adding to String of Deals
March 4, 2026
·
2 min read
·
Tristan Manalac
